Association of single-nucleotide polymorphisms in the cannabinoid receptor 2 gene with schizophrenia in the Han Chinese population

Journal of Molecular Neuroscience

Volumn 51, Issue 2, 2013, Pages 454-460

  Tong, Dongxiao ^a   He, Shuping ^b   Wang, Liwen ^a   Jin, Lu ^a   Si, Peiru ^a   Cheng, Xiaoli ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b Zhengzhou Mental Health Hospital   (China)

Author keywords

Cannabinoid receptor 2; Polymorphism; Schizophrenia

Indexed keywords

CANNABINOID RECEPTOR; CANNABINOID RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENES, DOMINANT; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, CANNABINOID, CB2; SCHIZOPHRENIA; SEX FACTORS;

EID: 84885188109     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-013-0062-0     Document Type: Article

References (23)

1. Carrier EJ, Kearn CS, Barkmeier AJ et al (2004) Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol Pharmacol 65:999-1007
2. Chen ZX, Chen HL (2008) Endogenous cannabinoid system and parkinsonism. J Apoplexy Nerv Dis 2:248-249
3. Facchinetti F, Del Giudice E, Furegato S et al (2003) Cannabinoids ablate release of TNF alpha in rat microglial cells stimulated with lypopolysaccharide. Glia 41:161-168
4. Fernández-Ruiz J, González S, Romero J et al (2005) Cannabinoids in neurodegeneration and neuroprotection. Cannabinoids Ther 10:79-109
5. Fernández-Ruiz J, Romero J, Velasco G et al (2007) Cannabinoid CB2 receptor: a new target for controlling neural cell survival. Trends Pharmacol Sci 28:39-45
6. Galve-Roperh I, Sánchez C, Cortés ML et al (2000) Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 6:313-319
7. García-Gutiérrez MS, Pérez-Ortiz JM, Gutiérrez-Adán A et al (2010) Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors. Br J Pharmacol 160:1773-1784
8. Guzmán M (2003) Cannabinoids: potential anticancer agents. Nat Rev Cancer 3:745-755
9. Hu Z, Li X, Qu X et al (2010) Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis. Carcinogenesis 31:643-647
10. Ishiguro H, Horiuchi Y, Ishikawa M et al (2010) Brain cannabinoid CB2 receptor in schizophrenia. Biol Psychiatry 67:974-982
11. Minocci D, Massei J, Martino A et al (2011) Genetic association between bipolar disorder and 524A > C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor. J Affect Disord 134:427-430
12. Molina-Holgado F, Molina-Holgado E, Guaza C et al (2002) Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide- induced nitric oxide release in astrocyte cultures. J Neurosci Res 67:829-836
13. Onaivi ES, Ishiguro H, Gong JP et al (2008) Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects. PLoS One 3:e1640
14. Ortega-Alvaro A, Aracil-Fernández A, García- Gutiérrez MS et al (2011) Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. Neuropsychopharmacology 36:1489-1504
15. Palazuelos J, Aguado T, Egia A et al (2006) Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation. FASEB J 20:2405-2407
16. Rossi F, Bellini G, Luongo L et al (2013) The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression. Pharmacol Res 68(1):7-15
17. Sherwood TA, Nong L, Agudelo M et al (2009) Identification of transcription start sites and preferential expression of select CB2 transcripts in mouse and human B lymphocytes. Neuroimmune Pharmacol 4:476-488
18. Stella N (2004) Cannabinoid signaling in glial cells. Glia 48:267-277
19. Suárez J, Llorente R, Romero-Zerbo SY et al (2009) Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB(1) and CB(2) cannabinoid receptors of neonatal rats. Hippocampus 19:623-632
20. Viscomi MT, Oddi S, Latini L et al (2009) Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the P13K/Akt pathway. Neurosci 29:4564-4570
21. Wang XB (2000) The new research progress about introns function. Chin J Med Genet 3:71-72
22. Xiao S, Zhang JJ (2009) Endogenous cannabinoid system and synaptic plasticity research progress. J Int Neurol Neurosurg 5:462-466
23. Yu HL, Zhang F, Quan ZS (2012) Endogenous cannabinoid system and depression. Prog Physiol Sci 4:257-262